InvaGen Pharmaceuticals, Inc.'s Net Worth
$3 Million
Who is InvaGen Pharmaceuticals, Inc.?
InvaGen Pharmaceuticals, Inc. has an estimated net worth of $3 Million. This is based on reported shares in AVENUE THERAPEUTICS, INC..
SEC CIK
InvaGen Pharmaceuticals, Inc.'s CIK is 0001759453
Past Insider Trading and Trends
2022 was InvaGen Pharmaceuticals, Inc.'s most active year for disposing of shares, totalling 1 transactions. InvaGen Pharmaceuticals, Inc.'s most active month to dispose stocks was the month of September. In 2022 InvaGen Pharmaceuticals, Inc. cashed out on 388,888 shares for a total of $2,999,882.03, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AVENUE THERAPEUTICS, INC. (ATXI) Snapshot price: $0.13031
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -388.89K |
$7.71 | -$2,999,882.03 |
0
|
Oct 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||